Hunan Hansen Pharmaceutical Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 681.15 million compared to CNY 659.92 million a year ago. Revenue was CNY 681.15 million compared to CNY 659.92 million a year ago.

Net income was CNY 130.07 million compared to CNY 113.49 million a year ago. Basic earnings per share from continuing operations was CNY 0.2585 compared to CNY 0.2255 a year ago. Diluted earnings per share from continuing operations was CNY 0.2585 compared to CNY 0.2255 a year ago.